Biosynex SA (EPA:ALBIO)
France
· Delayed Price · Currency is EUR 0.864
-0.026 (-2.92%)
Mar 9, 2026, 5:35 PM CET
Biosynex Company Description
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally.
The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention.
It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products.
The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Biosynex SA
| Country | France |
| Founded | 1993 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 454 |
| CEO | Larry Abensur |
Contact Details
Address: 22 Boulevard SEbastien Brant Illkirch-Graffenstaden, 67400 France | |
| Phone | 33 3 88 78 78 87 |
| Website | biosynex.com |
Stock Details
| Ticker Symbol | ALBIO |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0011005933 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Thierry Paper | Deputy Chief Executive Officer and Director |
| Larry Abensur | Chairman and Chief Executive Officer |